An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: A per-protocol and completers analysis

BACKGROUND: The distinct pharmacological properties and clinical uses of extended-release naltrexone (XR-NTX) and sublingual buprenorphine-naloxone (BUP-NX) present challenges in analyzing patient outcomes. METHODS: We conducted a secondary analysis of a multi-site randomized trial comparing XR-NTX...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Alcohol Depend
Main Authors: Mitchell, Mary M., Schwartz, Robert P., Choo, Tse-Hwei, Pavlicova, Martina, O’Grady, Kevin E., Gryczynski, Jan, Stitzer, Maxine L., Nunes, Edward V., Rotrosen, John
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8034542/
https://ncbi.nlm.nih.gov/pubmed/33352487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2020.108422
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados